Advantage Investment Management’s Timken Company TKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$34K Sell
786
-94
-11% -$4.15K 0.03% 416
2019
Q2
$45K Hold
880
0.03% 370
2019
Q1
$38K Buy
880
+116
+15% +$4.93K 0.03% 402
2018
Q4
$29K Hold
764
0.02% 449
2018
Q3
$38K Buy
764
+712
+1,369% +$33.6K 0.02% 441
2018
Q2
$2K Hold
52
﹤0.01% 881
2018
Q1
$2K Hold
52
﹤0.01% 924
2017
Q4
$3K Hold
52
﹤0.01% 893
2017
Q3
$3K Hold
52
﹤0.01% 908
2017
Q2
$2K Hold
52
﹤0.01% 984
2017
Q1
$2K Hold
52
﹤0.01% 911
2016
Q4
$2K Hold
52
﹤0.01% 865
2016
Q3
$2K Hold
52
﹤0.01% 842
2016
Q2
$2K Hold
52
﹤0.01% 798
2016
Q1
$2K Hold
52
﹤0.01% 788
2015
Q4
$1K Hold
52
﹤0.01% 838
2015
Q3
$1K Hold
52
﹤0.01% 807
2015
Q2
$2K Hold
52
﹤0.01% 796
2015
Q1
$2K Hold
52
﹤0.01% 793
2014
Q4
$2K Buy
+52
New +$2.19K ﹤0.01% 723

Other funds holding TKR

Advantage Investment Management's TKR Position: Q3 2019 in Review

Advantage Investment Management reduced its Timken Company (TKR) stake by 11% in Q3 2019, selling an estimated $4.15K and leaving 786 shares worth $34K. The position accounts for 0.03% of the portfolio, ranked #416.

Advantage Investment Management first reported a position in TKR in Q4 2014 and has held it in 20 quarters since. The position peaked at $45K in Q2 2019. 339 funds tracked by Wall St. Rank hold TKR as of Q3 2019.

  • Advantage Investment Management held 786 shares of Timken Company worth $34K as of Q3 2019.
  • Advantage Investment Management sold 94 Timken Company shares in Q3 2019, an estimated $4.15K.
  • Timken Company made up 0.03% of Advantage Investment Management's portfolio in Q3 2019, its #416 holding.
  • Advantage Investment Management first reported a position in Timken Company in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's Timken Company position peaked at $45K in Q2 2019.
  • 339 funds tracked by Wall St. Rank held Timken Company as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.